Ciox Announces Four New ROI Customers
Comprehensive ROI Network, Robust Services and Technology Platform: Key Drivers in Continued Market Growth
ALPHARETTA, Ga. – July 11, 2019 – Ciox announces today a wave of new agreements inked between the health data technology leader and several leading healthcare providers around the country, including:
- Dana-Farber Cancer Institute – Boston, MA
- Genotox Laboratories – Austin, TX
- San Antonio Regional Hospital – Upland, CA
- Summit Medical Group – New Providence, NJ
These new clients reflect the broader market-disrupting momentum achieved by Ciox since releasing HealthSource, its flagship health technology platform. With HealthSource, which was launched in 2018, Ciox offers a cloud-based clinical data platform that utilizes artificial intelligence technologies to ensure health data is securely obtained, authenticated and delivered to requestors in a digital, interoperable and highly efficient manner.
For the Dana-Farber Cancer Institute, Ciox’s people, technology and favorable references were the driving factors in finalizing the agreement.
“Dana-Farber Health Information Services chose Ciox Health due to its reputation in the industry, cutting-edge technology, focus on customer service and staff development,” says John Avedian, HIM director at Dana-Farber.
Ciox’s scalability and the combination of both on-site resources and newer, digital capabilities also played a role in the other signings announced today.
“The future of medical records is ubiquitous access to records no matter the format or location. We’re building a network of technologies and services that ensure our clients can manage the release of health information securely, efficiently and digitally, for anyone, anywhere,” says Pete McCabe, chief executive officer for Ciox. “For Ciox clients, our people and our technology provide better and more accurate data, delivered faster and more accurately than ever before. It means better audits, scalability to any size and improved revenue cycles.”
Both Summit Medical Group and Genotox Laboratories selected Ciox for its capabilities to handle requests at volumes. Summit is a large medical practice – with nearly 1000 healthcare practitioners at more than 85 locations and anticipated growth in the coming years – so the practice needs partners that can grow and scale.
“Ciox handled our new account with the utmost professionalism from point of contact to our current transition period,” says Maciel Gonzalez, HIMS manager at Summit Health Management. “The service that Ciox has provided us has been exceptional and I’m looking forward to a wonderful working relationship for years to come.”
An inundation of audits from health plans led Genotox to tap Ciox for Audit Relief Services.
“Today, Ciox will handle all of our audit-related requests so our staff can get back to the business of running a cutting-edge laboratory,” Alex DiGiacomo, Director of Revenue Cycle at Genotox Laboratories. “Thanks to the ROI services and support from Ciox, we can focus on managing what we do best – providing healthcare professionals with accurate, dependable, and actionable toxicology services.”
Leave a ReplyWant to join the discussion?
Feel free to contribute!